Loss of USP22 alleviates cardiac hypertrophy induced by pressure overload through HiF1-α-TAK1 signaling pathway
- 23 July 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1869 (8) , 166813
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (82170265)
- National Natural Science Foundation of China
This publication has 36 references indexed in Scilit:
- Hypoxia-Inducible Factor 1 and Cardiovascular DiseaseAnnual Review of Physiology, 2014
- The Ubiquitin CodeAnnual Review of Biochemistry, 2012
- Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in miceJournal of Clinical Investigation, 2011
- Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overloadJournal of Clinical Investigation, 2011
- Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological StimulationCirculation, 2010
- Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking TalePhysiological Reviews, 2010
- Sent to DestroyCirculation Research, 2010
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle ProgressionMolecular Cell, 2008
- Death-From-Cancer Signatures and Stem Cell Contribution to Metastatic CancerCell Cycle, 2005